Chimerix Inc (CMRX)
0.9351
-0.07
(-7.42%)
USD |
NASDAQ |
Nov 07, 16:00
0.9818
+0.05
(+4.99%)
After-Hours: 20:00
Chimerix Revenue (Annual): 0.324M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.324M |
| December 31, 2022 | 33.82M |
| December 31, 2021 | 1.979M |
| December 31, 2020 | 5.372M |
| December 31, 2019 | 12.52M |
| December 31, 2018 | 7.216M |
| December 31, 2017 | 4.494M |
| Date | Value |
|---|---|
| December 31, 2016 | 5.702M |
| December 31, 2015 | 10.76M |
| December 31, 2014 | 4.04M |
| December 31, 2013 | 4.37M |
| December 31, 2012 | 33.72M |
| December 31, 2011 | 12.10M |
| December 31, 2010 | 1.715M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.324M
Minimum
2023
33.82M
Maximum
2022
10.80M
Average
5.372M
Median
2020
Revenue (Annual) Benchmarks
| SIGA Technologies Inc | 139.92M |
| Abbott Laboratories | 40.11B |
| Emergent BioSolutions Inc | 1.023B |
| Tonix Pharmaceuticals Holding Corp | 7.768M |
| Geovax Labs Inc | -- |